Excelsior Medical Co Ltd (TW:4104) — Market Cap & Net Worth
Market Cap & Net Worth: Excelsior Medical Co Ltd (4104)
Excelsior Medical Co Ltd (TW:4104) has a market capitalization of $426.70 Million (NT$13.54 Billion) as of September 18, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #13150 globally and #502 in its home market, demonstrating a 1.13% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Excelsior Medical Co Ltd's stock price NT$71.90 by its total outstanding shares 188367456 (188.37 Million). Also see Excelsior Medical Co Ltd (4104) total assets for a full breakdown of the balance sheet.
Excelsior Medical Co Ltd Market Cap History: 2015 to 2026
Excelsior Medical Co Ltd's market capitalization history from 2015 to 2026. Data shows growth from $202.96 Million to $426.70 Million (7.38% CAGR). Also see cash flow conversion of Excelsior Medical Co Ltd for how efficiently the company converts equity into cash flow.
Excelsior Medical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Excelsior Medical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Excelsior Medical Co Ltd (4104) stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.06x
Excelsior Medical Co Ltd's market cap is 0.06 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.66x
Excelsior Medical Co Ltd's market cap is 0.66 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $202.96 Million | $6.20 Billion | $379.00 Million | 0.03x | 0.54x |
| 2016 | $194.61 Million | $6.21 Billion | $389.56 Million | 0.03x | 0.50x |
| 2017 | $203.22 Million | $6.10 Billion | $399.05 Million | 0.03x | 0.51x |
| 2018 | $219.63 Million | $6.35 Billion | $451.56 Million | 0.03x | 0.49x |
| 2019 | $271.35 Million | $6.46 Billion | $514.75 Million | 0.04x | 0.53x |
| 2020 | $298.12 Million | $6.68 Billion | $571.67 Million | 0.04x | 0.52x |
| 2021 | $324.49 Million | $6.57 Billion | $607.15 Million | 0.05x | 0.53x |
| 2022 | $401.18 Million | $7.19 Billion | $667.45 Million | 0.06x | 0.60x |
| 2023 | $524.62 Million | $8.23 Billion | $746.61 Million | 0.06x | 0.70x |
| 2024 | $510.38 Million | $8.54 Billion | $771.26 Million | 0.06x | 0.66x |
Competitor Companies of 4104 by Market Capitalization
Companies near Excelsior Medical Co Ltd in the global market cap rankings as of September 18, 2026. Review Excelsior Medical Co Ltd (4104) tangible equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Excelsior Medical Co Ltd by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #249 globally with a market cap of $101.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #542 globally with a market cap of $50.53 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #642 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1221 globally with a market cap of $21.15 Billion USD ( AU$29.90 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #249 | McKesson Corporation | NYSE:MCK | $101.38 Billion | $887.29 |
| #542 | Cencora Inc. | NYSE:COR | $50.53 Billion | $318.50 |
| #642 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $232.54 |
| #1221 | Sigma Healthcare Ltd | AU:SIG | $21.15 Billion | AU$2.59 |
Excelsior Medical Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Excelsior Medical Co Ltd's market cap moved from $202.96 Million to $ 426.70 Million, with a yearly change of 7.38%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$426.70 Million | -11.89% |
| 2025 | NT$484.26 Million | -5.12% |
| 2024 | NT$510.38 Million | -2.71% |
| 2023 | NT$524.62 Million | +30.77% |
| 2022 | NT$401.18 Million | +23.63% |
| 2021 | NT$324.49 Million | +8.84% |
| 2020 | NT$298.12 Million | +9.87% |
| 2019 | NT$271.35 Million | +23.55% |
| 2018 | NT$219.63 Million | +8.08% |
| 2017 | NT$203.22 Million | +4.42% |
| 2016 | NT$194.61 Million | -4.11% |
| 2015 | NT$202.96 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of Excelsior Medical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $426.70 Million USD |
| MoneyControl | $426.70 Million USD |
| MarketWatch | $426.70 Million USD |
| marketcap.company | $426.70 Million USD |
| Reuters | $426.70 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Excelsior Medical Co Ltd
Excelsior Medical Co., Ltd., together with its subsidiaries, sells medical supplies and equipment, medicines, and home medical devices in Taiwan, Hong Kong, China, the Philippines, Malaysia, and Indonesia. It operates in four segments: Excelsior, Dynamic, Arich, and Other. The company offers hemodialysis/plasma exchange; blood bags; artificial stomas; and health appliances. It is also involved in… Read more